Safe Epigenetic Reprogramming Enables Simultaneous Multi-Gene Editing in T Cells for Enhanced CAR-T Therapies
In a stunning leap forward for immunotherapy, researchers from the Arc Institute, Gladstone Institutes, and the University of California, San ...